Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing

Remote Areas See Sharpest Drops in Nursing Home Residents Amid Preference for Home-Based Services
Between 2015 and 2025 the U.S. nursing home stock shrank 6%, with rural facilities accounting for half the closures. Resident numbers fell fastest in remote rural areas, dropping 19% versus an 8% decline in urban settings, signaling a shift toward home‑based care. The 2025 federal reconciliation law is expected to cut Medicaid spending by $911 billion over a decade, including $137 billion in rural cuts, while only $50 billion is earmarked for a rural health transformation program. State proposals targeting rural nursing homes remain scarce.

“They Just Walked Away”: Maine Senate Kills Transparency Bill Amid DHHS Controversy - MWTV
The episode covers the heated fight over Maine’s LD‑127 transparency bill, which would let a bipartisan oversight committee access DHHS records on child welfare deaths. Host Tom Shattuck and panelists detail how the Senate rushed to adjourn and “sign‑die” the...
Healthcare Systems Vie To Keep Up With DFW's Growth While Remaining Flexible For The Future
Dallas‑Fort Worth’s northern suburbs are experiencing rapid population growth, positioning the metro area to overtake Chicago as the third‑largest U.S. metro by 2035. Healthcare systems such as Cook Children’s and Baylor Scott & White are expanding with megacampuses, micro‑hospitals, and flexible office spaces...

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics
The Trump administration announced that marijuana will be re‑classified from Schedule I to Schedule III in states that have authorized medical use, and the Justice Department scheduled a June hearing on a nationwide re‑classification. The same administration issued executive orders to increase...
Robotic-Assisted Pedicle Screw Placement Achieves High Accuracy and Narrows the Experience Gap: A Preclinical Evaluation
A preclinical study evaluated the Mako Spine robotic system against conventional open fluoroscopy for thoracolumbar pedicle screw placement in synthetic torsos. Across 255 screws, the robotic approach achieved a 97.6% clinically acceptable rate and a 74% optimal placement rate, outperforming...

Federal Court Mulls Psychedelics Access for Homebound, Terminally Ill
A federal district court in Oregon has allowed a lawsuit challenging the state's Psilocybin Services Act to move forward. The suit, filed by licensed facilitators, claims the law’s requirement that psilocybin be administered only in licensed service centers violates the...

Can Facet Arthroplasty Outperform TLIF for Spondy?
A prospective, multicenter FDA IDE trial compared the Total Posterior Spine (TOPS) facet arthroplasty system with traditional transforaminal lumbar interbody fusion (TLIF) in patients with single‑level grade I degenerative spondylolisthesis. At 24 months, TOPS achieved an 85% composite clinical success rate versus...
Long a Dream, It's Now Real: A Fast and Accurate TB Test that Doesn't Need Phlegm
A Chinese firm, Pluslife, has commercialized the MiniDock MTB, a portable tuberculosis test that works with a simple tongue swab or sputum and costs about $300 per device and $3‑4 per assay. In a study of nearly 1,400 patients across...

Knee Surgery for Cartilage Damage Does Not Benefit Patients, Study Suggests
A 10‑year randomized trial in Finland found that partial meniscectomy for knee cartilage tears offers no benefit and may worsen outcomes. Patients who received the surgery reported poorer knee function, higher osteoarthritis progression, and increased likelihood of additional procedures compared...

The Cost of Chaos in Medical Malpractice Litigation
Two recent malpractice cases illustrate how legal tactics can inflate costs. A teenage mother’s premature birth led to a $200 million plaintiff verdict that was later overturned after a two‑year appeal, revealing that delayed prenatal care, not hospital negligence, caused the...
FIT-DNA Shows Modest Advantage Over FIT for CRC Screening in Community Health Centers
A pragmatic cluster‑randomized trial in eight community health centers found that mailed FIT‑DNA kits modestly outperformed standard FIT kits, achieving 27.9% screening participation at 90 days versus 22.6% for FIT. The advantage persisted at 180 days, especially among Hispanic, Spanish‑speaking,...
Leveraging Sociodemographic, Digital Exposure, and Knowledge-Based Empowerment Factors to Improve Maternal Health Behaviour Among Married Women in Nigeria: A Cross-Sectional...
A new analysis of Nigeria’s 2018 Demographic and Health Survey examined how sociodemographic factors, digital exposure, and knowledge‑based empowerment affect maternal health behaviours among 28,888 married women. The study found that mobile phone ownership, internet use, and receipt of health...

New Brain Insights May Inform Rehab After Stroke or Brain Injury
Researchers at Yale discovered that retaining newly learned speech movements relies chiefly on sensory brain processes rather than motor regions. Using real‑time speech alteration and transcranial magnetic stimulation, they showed that disrupting auditory or somatosensory cortex impairs memory of speech...

Autopsy Studies Turn Sudden Cardiac Death Wisdom on Its Head
A 12‑year autopsy‑based POST SCD study in San Francisco County found that only 41% of sudden cardiac deaths (SCD) are attributable to myocardial infarction, challenging the long‑standing belief that roughly 80% are MI‑related. The analysis of 943 out‑of‑hospital cardiac arrests...
BIOTECanada Responds to Health Canada’s Gazette on Modernizing Clinical Trials Regulations
Health Canada has released a Gazette notice proposing modernized clinical‑trial regulations and draft guidance for decentralized trials. BIOTECanada welcomed the initiative but urged that the new rules align with the U.S. FDA and European EMA to avoid duplicative requirements. The...
Marvin AI Teams with VA and Regional Medical Societies to Support 45,000 Clinicians
Marvin AI announced partnerships with the Veterans Health Administration and a consortium of medical societies spanning five states, extending its behavioral‑health platform to more than 45,000 clinicians in ten states. The move targets burnout, a pressing workforce issue as healthcare...
Duodenal Mucosal Resurfacing Cuts Post‑GLP‑1 Weight Regain by 40% in First Trial
Researchers at Dartmouth Health presented the first sham‑controlled trial of duodenal mucosal resurfacing, showing participants who received the endoscopic “gut reset” regained 40% less weight than controls after stopping GLP‑1 drugs. The findings could address a major gap in obesity...

Lawmakers Urged by AHA to Support Key Health Initiatives in FY 2027 Appropriations Bill
The American Hospital Association (AHA) urged House and Senate appropriations committee leaders to prioritize funding for a suite of health‑care initiatives in the FY 2027 appropriations bills. The association highlighted programs that improve workforce capacity, maternal and child health, rural access,...

GLP-1 Drugs May Lower CV Risk in TAVI Patients With Diabetes or Obesity
A retrospective analysis of 1,708 matched TAVI patients shows that glucagon‑like peptide‑1 (GLP‑1) receptor agonists cut the relative risk of major adverse cardiovascular events (MACE) by 37% and all‑cause mortality by 39% at one year. The benefit was consistent in...
Every Day Brings Unpredictable Moments in Hospice Social Work
The role of a hospice social worker is different every single day. So far this week: Monday: I met a patient who believes the earth is flat. (Before you ask, no brain cancer or mets, just some unique ideas.) Tuesday: I met...
Humana Q1 Profit Falls to $1.18 Billion as Medical Costs Rise
Humana Inc. posted first‑quarter profit of $1.18 billion, down from $1.24 billion a year earlier, as medical cost inflation eroded margins. Revenue surged 23.5% to $39.64 billion, reflecting higher enrollment and service utilization. The results underscore pressure on U.S. health‑insurers and signal broader...

AHRQ Seeks Nominees to Serve on U.S. Preventive Services Task Force
The Agency for Healthcare Research and Quality (AHRQ) has opened nominations for new members of the U.S. Preventive Services Task Force (USPSTF). While all candidates will be reviewed, the agency is especially seeking physician specialists in fields such as cardiology,...
Small Stem Cell Edit Generates Persistent Antibody Protection
Researchers showed that editing a small number of blood stem cells can reprogram the immune system to continuously produce therapeutic proteins, including powerful antibodies that are normally hard to generate. In mice, this approach created long-lasting, boostable protection against infections...
2C‑B Shows Dose‑Dependent Effects Similar to MDMA and Psilocybin
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants https://t.co/OEJPk0XTqg

Researchers: FDA-Cleared Chest X-Ray AI Shows Promise in Missed Lung Cancer Detection
Researchers presented a study at the ARRS 2026 meeting showing that the FDA‑cleared AI solution qXR‑LN can detect lung nodules missed on routine chest X‑rays, achieving a 26.7% detection rate and identifying 40% of early‑stage cancers. The retrospective analysis at...
PTC Therapeutics Sees 52% Slowing of Huntington's Disease with Votoplam
PTC Therapeutics reported that participants with Stage 2 Huntington's disease receiving 10 mg of Votoplam experienced a 52% slowdown in disease progression over 24 months, compared with a matched natural‑history cohort. The data, presented in a press release on April 28, 2026, reinforce...

High Hopes or Higher Anxiety?
The article reviews the mixed and limited evidence for using cannabis to treat mental‑health disorders. It highlights that high‑THC cannabis can exacerbate anxiety, depression, and trigger psychotic episodes, especially in vulnerable individuals. Studies show no conclusive benefit of cannabis for...
UChicago Medicine Deploys Artisight’s Smart Hospital Platform in 1,800 Rooms
UChicago Medicine has signed an enterprise agreement with AI‑health firm Artisight to install its Smart Hospital Platform in more than 1,800 patient rooms, surgical suites and post‑anesthesia care units. The rollout aims to automate documentation, cut bedside nurses’ administrative workload...

More Serious Flaws Are Overlooked in the Dispute over Respirators Versus Surgical Masks
A recent BMJ rapid response challenges the Loeb et al. randomized trial that compared N95 respirators with medical masks for health‑care workers. The author argues the study suffers from a "similarity" flaw—participants’ off‑work COVID exposure was untracked—and a "difference" flaw—unmeasured susceptibility...
CareDx Q1 2026 Earnings: COO Keith Kennedy Highlights 39% Revenue Rise and $170 M Lab Divestiture
CareDx posted $118 million in first‑quarter revenue, up 39% year over year, as COO and CFO Keith S. Kennedy detailed a shift toward higher‑margin testing services, a $170 million lab‑products divestiture, and a push for operational efficiency. The results set a new...
Mehmet Oz Calls for Texas Hospice Fraud Probe, Expands Nationwide Medicaid Audit
CMS Administrator Mehmet Oz announced a targeted investigation of hospice providers in Texas, citing a surge in licenses since 2020. The move follows a Los Angeles task force that shut down 450 hospices and paused $600 million in payments, and it expands...

AI May Spot ADHD Years Before Kids Get Diagnosis
Researchers at Duke University used artificial intelligence to scan routine electronic health records from over 140,000 children and predict the risk of developing ADHD years before a formal diagnosis. The model identified patterns of developmental, behavioral and clinical events that...

Payment Models Taking Shape for Advanced Therapies: Fran Gregory, PharmD
Advanced therapies priced up to $4 million are prompting a rethink of how they are funded. Fran Gregory of Cardinal Health says the gap between limited launch data and payer expectations can be bridged with robust real‑world evidence. The company is...
Ghana Rejects $109 Million U.S. Health Aid Deal Over Data‑Sharing Terms
Ghana has turned down a proposed five‑year, $109 million U.S. health assistance agreement because of demands to share sensitive health data. The decision underscores growing friction between Washington’s “America First Global Health Strategy” and low‑income nations wary of data sovereignty.

PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
PROCEPT BioRobotics reported first‑quarter 2026 revenue of $83.1 million, a 20% year‑over‑year increase driven by stronger U.S. system sales and higher pricing. The company performed about 12,200 Aquablation procedures in the U.S., a 30% rise, and grew its Hydros install base...

MIMEDX Announces First Quarter 2026 Operating & Financial Results
MiMedx Group reported first‑quarter 2026 net sales of $59 million, a 33% drop from the prior year, as new Medicare reimbursement rules crippled its wound‑care segment, which fell 60%. The surgical franchise bucked the trend, posting a 13% year‑over‑year increase. Management...

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Olema Oncology announced the appointment of Dr. Prakash Raman, a veteran biotech executive, to its Board of Directors. Raman, currently CEO of InduPro Therapeutics, brings more than two decades of experience in business development and corporate strategy, including senior roles...

A Political History of Australian Health Policy, Part 4: Medibank to Medicare, 1969-1984
The article traces Australia’s health‑policy evolution from the 1969 Medibank experiment to the 1984 establishment of Medicare. It details how political swings in the 1970s—particularly the 1976 repeal of Medibank—generated fierce public debate over universal coverage versus private insurance. The...
Rocket Pharmaceuticals Secures $180 Million From Priority Review Voucher Sale
Rocket Pharmaceuticals sold its FDA rare‑pediatric‑disease priority review voucher for $180 million, extending its cash runway into the second quarter of 2028 and providing non‑dilutive capital for its cardiovascular gene‑therapy pipeline. The deal underscores the growing market for FDA vouchers as...
Official Style Guide Resolves Long‑Debated Health Writing Detail
After YEARS of debate… It’s official- You know that one tiny detail you always second-guess when writing? Yeah… there’s finally an answer. Somewhere, every health journalist just breathed a sigh of relief 😅 Next up: payer vs payor… see you in 2035. #healthcare #payer...
Medtronic Wins FDA Approval for Updated Mitral Replacement Valve
Medtronic announced FDA approval for its next‑generation Mosaic Neo bioprosthetic mitral valve and has begun U.S. launches. The valve can be implanted via traditional sternotomy or minimally invasive approaches, and the company performed the first combined implant with its Penditure left‑atrial‑appendage...

FDA Confirms Safety of U.S. Infant Formula Supply
The FDA announced on April 29 that its testing of more than 300 infant‑formula products found contaminant levels to be undetectable or well below safety limits, concluding the U.S. supply is safe. The agency screened for lead, mercury, cadmium, arsenic, glyphosate,...
CMS Rules Compliance Will Improve Patient Experiences
The Centers for Medicare & Medicaid Services (CMS) will enforce new interoperability rules in 2027 that require real‑time disclosure of prior‑authorization requirements through FHIR‑based APIs. According to eHealth Exchange consultant Scott Rossignol, the mandate will let patients see when a prior...

Morningstar DBRS Confirms Lakeridge Health's Credit Ratings at AA, Stable Trends
Morningstar DBRS reaffirmed Lakeridge Health’s issuer and senior unsecured debenture ratings at AA with a Stable trend, emphasizing the province’s robust financial backing. The Durham‑region hospital is a key acute‑care provider for a fast‑growing population, yet it has posted consecutive...

Semaglutide Restores Lacrimal Gland, Relieves Age‑Related Dry Eye
Semaglutide alleviates age-related dry eye disease by restoring lacrimal gland structure and function https://t.co/EDvPtdeiqg https://t.co/Kpku8SHEOH

AI Finds 38 Security Flaws in Electronic Health Record Platform
Aisle's AI-powered scanner identified 38 previously unknown vulnerabilities in the open‑source OpenEMR platform, which serves over 100,000 providers worldwide. The flaws, spanning medium to critical severity, include SQL injection, cross‑site scripting, path traversal and authorization bypasses. OpenEMR released version 8.0.0 and...

AHA Podcast Highlights Menopause Care and Need to Close Gaps in Medical Training
The American Hospital Association’s podcast features University of Illinois Chicago experts Pauline Maki, Ph.D., and Makeba Williams, M.D., discussing a breakthrough moment in menopause care. They detail how menopause influences brain function, mood, and cardiovascular health, while highlighting the stark...

Man Who Had Alleged Brain Injury After Contracting Meningitis as Baby Settles Case for €9.75m
A 25‑year‑old man from Limerick, who alleges a lifelong brain injury from meningitis contracted at birth, settled his High Court claim against the Health Service Executive for €9.75 million (approximately $10.6 million). The case centered on alleged delays at St Munchin’s Regional Maternity...

Does Chronic Itching Set the Brain up for Depression?
Researchers at North Carolina State University argue that chronic itching from atopic dermatitis (AD) may directly rewire brain circuits, increasing depression risk. While AD patients are known to be seven times more likely to develop major depressive disorder, the team...

WTWH Healthcare Now Accepting Nominations For the Inaugural Product of the Year Awards
WTWH Healthcare has launched the first Home Health Care News (HHCN) Product of the Year Awards, inviting manufacturers to nominate innovative products, solutions and technologies for the home health and home care sector. Nominations are accepted from April 27 to June 30, 2026...